2013, Número 1
<< Anterior Siguiente >>
Gac Med Mex 2013; 149 (1)
Suplementación de micronutrimentos en mujeres con estados hipertensivos del embarazo (EHE)
de la Rosa PJA, Garduño-Alanís A, Meneses-Calderón J, Rueda-Villalpando JP, Salinas-Ramírez V, Herrera VJE
Idioma: Español
Referencias bibliográficas: 73
Paginas: 46-52
Archivo PDF: 109.16 Kb.
RESUMEN
El embarazo presenta un gran número de adaptaciones metabólicas, incrementando los requerimientos de macro y micronutrimentos, que no siempre son cubiertos por la dieta, haciendo necesaria la suplementación de algunos de ellos. Los micronutrimentos son parte importante de reacciones metabólicas, y tanto su deficiencia como su exceso pueden participar en daños a diversos órganos y tejidos de la madre y del feto. Actualmente, los estados hipertensivos del embarazo (EHE) participan dentro de las primeras causas de mortalidad durante el embarazo, haciendo necesaria la búsqueda de intervenciones que permitan prevenir o disminuir las posibles consecuencias. Se ha vinculado el grado de estrés oxidativo con el riesgo de desarrollar algún EHE, lo que ha creado hipótesis sobre el uso de micronutrimentos con poder antioxidante y su posible participación como protectores en estas patologías, sin embargo, la información aún es incierta y no se conoce con precisión la acción metabólica del uso de los multivitamínicos, puesto que algunos han mostrado tener un efecto protector en el desarrollo de los EHE. Es necesario evaluar el estado de nutrición previo y durante el embarazo, así como realizar estudios al respecto y fortalecer políticas públicas sobre el uso de micronutrimentos en el embarazo.
REFERENCIAS (EN ESTE ARTÍCULO)
Lerberghe WV, Manuel A, Matthews Z, Wolfheim C, Prentice T. Informe sobre la salud en el mundo. Cada madre y cada niño contarán. Suiza: Organización Mundial de la Salud; 2005. p. 239.
Centro Nacional de Equidad y Género y Salud Reproductiva. Prevención, diagnóstico y manejo de la preeclampsia/eclampsia. México, D.F.: Secretaría de Salud; 2007. p. 1-60.
Mataix J, Aranda P. Gestación. En: Mataix J. Tratado de nutrición y alimentación. Tomo 2. Situaciones fisiológicas y patológicas. Nueva edición ampliada. Barcelona: Océano/Ergon; 2008. p. 161-1084.
Ashworth CJ, Antipatís C. Micronutrient programming of development throughout gestation. Reproduction. 2001;122:257-535.
Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy. Dtsch Arztebl Int. 2009;106:733-8.
Williams PJ, Broughton F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:405-17.
Oken E. Excess gestational weight gain amplifies risks among obese mothers. Epidemiology. 2009;20:82-3.
Jin-hua L, Yi-ke Y, Hua L, Qi-de L, Wei-yuan Z. Effect of antioxidants on amelioration of high-risk factors inducing hypertensive disorders in pregnancy. Chin Med J. 2010;123(18):2548-54.
Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci. 2010;119:123-9.
McCance DR, Holmes VA, Maresh MJA, et al. Vitamin C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomized placebo-controlled trial. Lancet. 2010;376:259-66.
Catov JM, Nohr EA, Bodnar LM, Knudson VK, Olsen SF, Olsen J. Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in Danish national birth cohort. Am J Epidemiol. 2009;169:1304-11.
Kharb S. Serum markers in pre-eclampsia. Biomarkers. 2009;14(6): 395-400.
Oken E, Ning Y, Rifas-Shiman SL, Rich-Edwards JW, Olsen SF, Gillman MW. Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol. 2007;17:663-8.
Mistry HD, Williams P. The importance of antioxidant micronutrients in pregnancy. Oxid Med Cell Longev. 2011;1-12.
Dakshinamurti K, Dakshinamurti S. Blood pressure regulation and micronutrients. Nutr Res Rev. 2001;14:3-43.
Xu H, Shatenstein B, Luo ZC, Wei S, Fraser W. Role of nutrition in the risk of preeclampsia. Nutr Rev. 2009;67(11):639-57.
Clagett-Dame M, Knutson D. Vitamin A in reproduction and development. Nutrients. 2011;3(4):385-428.
LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension. 2008;51:982-8.
Kolusari A, Kurdoglu M, Yildizhan R, et al. Catalase activity, serum trace element and heavy metal concentrations, and vitamin A, D and E levels on pre-eclampsia. J Int Med Res. 2008;36(6):1335-41.
Zhang C, Williams MA, Sánchez SE, et al. Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women. Am J Epidemiol. 2001;153:572-80.
Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Physiol. 2008;249:541-50.
Merchant AT, Msamanga G, Villamor E, et al. Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension. J Nutr. 2005;135:1776-81.
Thaver D, Saeed MA, Bhutta ZA. Pyridixine (vitamin B6) supplementation in pregnancy [review]. Cochrane Database Syst Rev. 2006;2:CD000179.
Heller S, Salkeld RM, Körner WF. Vitamin B6 status in pregnancy. Clin Nutr. 1973;26:1339-48.
O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010;2(3):299-316.
Chauvet E, Youssef M, Boukhari R, El Guindi W, Carles G. Symptoms of HELLP syndrome due to vitamin B12 deficiency: report of seven cases. J Gynecol Obstet Biol Reprod. 2009;38:226-30.
Yajnik CS, Deshpande SS, Jackson AA, et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune maternal nutrition study. Diabetologia. 2008;51:29-38.
Makedos G, Papanicolaou A, Hitoglou A, et al. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Arch Gynecol Obstet. 2007;275:121-4.
Acilmis YG, Dikensoy E, Kutlar AI, et al. Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia. J Obstet Gynaecol Res. 2011;37:45-50.
Deshmukh US, Joglekar CV, Lubree HG, et al. Effect of physiological doses of oral vitamin B12 on plasma homocysteine – A randomized, placebo-controlled, double-blind trial in India. Eur J Clin Nutr. 2010;64:495-502.
Patrick TE, Powers RW, Daftary AR, Ness RB, Roberts M. Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension. 2004;43:1279-82.
Roberts JM, Myatt L, Spong CY, et al. Vitamin C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362:1282-91.
Villar J, Purwar M, Merrialdi M, et al. World Health Organization multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG. 2009;116:780-8.
Casanueva E, Angulo ME, Goidberg S, et al. Base para estimar necesidades de vitamina C en la gestación. Gac Méd Méx. 2005;141:273-7.
Bastani P, Hamdi K, Abasalizadeh F, Navali N. Effects of vitamin E supplementation on some pregnancy health indices: a randomized clinical trial. Int J Gen Med. 2011;4:461-4.
Talaulikar VS, Manyonda IT. Vitamin C as an antioxidant supplement in women’s health: a myth in need of urgent burial. Eur J Obstet Gynecol Reprod Biol. 2011;157:10-3.
Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv. 2010;65:653-67.
Bakheit KH, Ghebremeskel K, Zaiger G, Elbashir MI, Adam I. Erythrocyte antioxidant enzymes and plasma antioxidant vitamins in Sudanese women with pre-eclampsia. J Obstet Gynaecol. 2010;30:147-50.
Berti C, Decsi T, Dykes F, et al. Critical issues in setting micronutrient recommendations for pregnant women: an insight. Matern Child Nutr. 2010;6:5-22.
Bodnar LM, Catov JM, Roberts JM, Simhan HN. Prepregnancy obesity predicts poor vitamin D status in mothers and their neonates. J Nutr. 2007;137:2437-42.
World Health Organization and Food and Agriculture Organization of the United Nations. Vitamin and mineral requirements in human nutrition. 2nd ed. Thailand: Report of a Join FAO/WHO Expert Consultation; 2004. p. 341.
Looker AC. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab. 2005;90:635-40.
Moy FM, Bulgiba A. High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among adults in Kuala Lumpur, Malaysia. BMC Public Health. 2011 Sep 27;11:735.
Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009;94:67-73.
Arunabh S, Pollack S, Yeh J, Alola JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88:157-61.
Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92:3517-22.
Baker AM, Haeri S, Camargo CA, Espinola JA, Stuebe AM. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab [internet]. 2010;95:5105-9 (consulta el 24 de noviembre de 2011). Disponible en: http://www.ncbi. nlm.nih.gov/pmc/articles/PMC2968727/?tool=pubmed
Robinson CJ, Alanis MS, Wagner CL, Hollis BW, Johnson DD. Plasma 25-OH-vitamin D levels in early onset, severe pre-eclampsia. Am J Obstet Gynaecol. 2010; 203:366.e1-6.
Haugen M, Brants.ter AL, Trogstad L, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009;20(5):720-6.
Powe CE, Seely EW, Rana S, et al. First trimester vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010;56:758-63.
World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: WHO Press; 2011. p. 1-38.
Greenberg JA, Bell SJ, Guan Y, Yu Y. Folic acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol. 2011;4:52-9.
Imdad A, Jabeen A, Bhutta Z. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Public Health. 2011;11(Suppl):18.
Dunlap B, Shelke K, Salem SA, Keith LG. Folic acid and human reproduction – Ten important issues for clinicians. J Exp Clin Assist Reprod. 2011;8:2.
Bánhidy F, Dakhlaoui A, Dudás I, Czeizel E. Birth outcomes of newborns after folic acid supplementation in pregnant women with early and late pre-eclampsia: a population-based study. Adv Prev Med. 2011;2011: 127369.
Buppasiri P, Lumbiganon P, Thinkhamrop J, Ngamjarus C, Laopaiboon M. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes [review]. Cochrane Database Syst Rev. 2011;10:CD007079.
Adamova Z, Ozkan S, Khalil RA. Vascular and cellular calcium in normal and hypertensive pregnancy. Curr Clin Pharmacol. 2009;4:172-90.
Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems [review]. Cochrane Database Syst Rev. 2010;CD111059.
Greiner T. Vitamins and minerals for women: recent programs and intervention trials. Nutr Res Pract. 2011;5:3-10.
Silva CA, Atallah AN Sass N, Mendes ET, Peixoto S. Evaluation of calcium and folic acid supplementation in prenatal care in São Paulo. Sao Paulo Med J. 2010;128:324-7.
Jabeen M, Yakoob MY, Imdad A, Bhutta ZA. Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BMC Public Health 2011;11(Suppl 3):6
Gupta A, Lutsenko S. Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med Chem. 2009;1: 1125-42.
Walker LR, Rattigan M, Carterino J. A case of isolated elevated copper levels during pregnancy. J Pregnancy. 2011;2011:385767.
Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr. 2005;81(Suppl):1218-22.
Singh J, O’Donovan M, Coulter-Smith SD, Geary M. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia. J Obstet Gynaecol. 2005;25:15-7.
Mistry HD, Wilson V, Ramsay MM, Symonds ME, Pipkin FB. Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension. 2008;52:881-8.
Mariath AB, Bergamaschi DP, Rondó PH, et al. The possible role of selenium status in adverse pregnancy outcomes. Br J Nutr. 2011;105: 1418-28.
Rayman MP, Wijnen H, Vader H, Kooistra L, Pop V. Maternal selenium status during early gestation and risk for preterm birth. CMAJ. 2011;183: 549-55.
Tara F, Maamouri G, Rayman MP, et al. Selenium supplementation and the incidence of preeclampsia in pregnant Iranian women: a randomized, double-blind, placebo-controlled pilot trial. Taiwan J Obstet Gynecol. 2010;49:181-7.
Bahadoran P, Zendehdel M, Movahedian A, Zahraee RH. The relationship between serum zinc level and preeclampsia. Iran J Nurs Midwifery Res [internet]. 2010;15:12-124 (consulta el 1 de diciembre de 2011). Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093166/?tool=pubmed.
Durán E, Soto D, Labraña AM, Pradenas F. Adecuación dietética de micronutrientes en embarazadas. Rev Chil Nutr [internet]. 2007;34 (consulta el 29 de agosto de 2011). Disponible en: http://www.scielo.cl/scielo. php?script=sci_arttext&pid=S0717-75182007000400005.
Bodnar LM, Tang G, Ness RB, Harger G, Roberts JM. Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol. 2006;164:470-7.
Haider BA, Yakoob MY, Bhuta ZA. Effect of multiple micronutrient supplementation during pregnancy on maternal and birth outcomes. BMC Public Health. 2011;11(Suppl):19.